April 1, 2026 · Form 4 insider transaction
Bernstein Harold sold 300 shares of Maze Therapeutics, Inc. at $31.07 per share, a transaction worth $9.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.80 to $31.22 per share, inclusive.